Global Guided Biofilm Therapy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

What is the Guided Biofilm Therapy Market Size and Growth Rate?

• As per Data Bridge Market Research analysis, the guided biofilm therapy market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 9.25% from 2026 to 2033.
• The market is experiencing strong growth driven by the rising prevalence of periodontal diseases, increasing awareness of preventive oral healthcare, growing adoption of minimally invasive dental procedures, and technological advancements in biofilm management and dental equipment.
• The increasing focus on preventive dentistry and effective management of dental biofilm, combined with the growing number of patients requiring periodontal and implant maintenance, is encouraging dental clinics and hospitals to adopt guided biofilm therapy. Airflow technology, ultrasonic scaling, and specialized GBT kits are increasingly being used to provide efficient, patient-friendly, and standardized biofilm removal and periodontal care.

Market Size & Forecast

• Global Market Value (2025): USD 1.05 Billion
• Expected Market Value (2033): USD 2.13 Billion
• Forecast CAGR (2026–2033): 9,25%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

What are the Major Takeaways of the Guided Biofilm Therapy Market?

• North America dominated the guided biofilm therapy market with the largest revenue share of 39.16% in 2025, supported by advanced dental infrastructure, high dental expenditure, and strong adoption of preventive and minimally invasive periodontal care.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 13.57% from 2026 to 2033, fueled by rising dental expenditure, expanding private dental clinics, increasing implant maintenance needs, and growing adoption in China, India, Japan, and other Asian markets
• The air polishing devices segment led the market with a 42.37% share in 2025, driven by their central role in removing dental biofilm, stains, and soft deposits with relatively low patient discomfort.
• Ultrasonic scaling devices are the fastest-growing product type, projected to register a CAGR of 9.82%, reflecting the surge in their complementary role in removing residual calculus after biofilm disclosure and air polishing.
• The air polishing systems segment dominated the technology category with a 41.59% revenue share in 2025, led by its fundamental role in the GBT treatment sequence and its ability to efficiently remove biofilm and extrinsic stains.
• Airflow technology accounted for 48.63% of the market share in 2025, preferred by its extensive use for removing biofilm, stains, and soft deposits during professional dental hygiene procedures
• The peri-implantitis segment is the fastest-growing indication category, with a CAGR of 10.17%, driven by the expanding population of patients with dental implants and increasing requirements for long-term implant maintenance.

Report Scope and Guided Biofilm Therapy Market Segmentation     

What is the Key Trend in the Guided Biofilm Therapy Market?

• Dental practices are increasingly adopting minimally invasive, patient-centered biofilm management protocols that combine biofilm disclosure, air polishing, ultrasonic instrumentation, and individualized periodontal maintenance to improve treatment comfort and workflow efficiency.
• For instance, in April 2025, EMS introduced the GBT Machine at IDS 2025, a next-generation prophylaxis system specifically optimized for guided biofilm therapy, with an emphasis on treatment efficiency, clinical precision, and patient comfort.
• Clinical evidence is increasingly supporting GBT as a comfortable and time-efficient alternative for professional biofilm and periodontal maintenance procedures.
• Dental professionals are also increasingly using erythritol-based air polishing and biofilm-disclosure techniques to improve plaque visualization and remove biofilm while reducing dependence on conventional mechanical instrumentation.
• For instance, in September 2024, an article published in BMC Oral Health involving 60 patients with stage III/IV periodontitis found that the GBT protocol reduced treatment time to 30.3 minutes versus 34.6 minutes for conventional treatment, supporting the trend toward more efficient, patient-friendly biofilm management.
• As dental practices increasingly prioritize patient comfort, shorter treatment times, minimally invasive procedures, and standardized preventive workflows, the adoption of integrated GBT systems and specialized consumables is expected to accelerate, reinforcing biofilm management as an important component of modern periodontal and preventive dental care.

What are the Key Drivers of the Guided Biofilm Therapy Market?

• The rising prevalence of periodontal disease and growing emphasis on preventive oral healthcare are increasing demand for effective professional biofilm-management solutions that can support periodontal maintenance and reduce plaque accumulation.
• For instance, in November 2024, a study published in the European Journal of Dentistry compared GBT with traditional scaling and root planing in patients with Stage III and IV periodontitis and concluded that GBT was a suitable approach for active periodontal treatment, reinforcing demand for minimally invasive biofilm-management protocols.
• Dental clinics, periodontal specialists, and implant-care providers are increasingly integrating air polishing, ultrasonic instrumentation, and biofilm disclosure into treatment protocols to provide more targeted and minimally invasive biofilm removal.
• or instance, in November 2024, an article published in the International Journal of Dental Hygiene found that a GBT protocol combining erythritol-powder air polishing and ultrasonic calculus removal reduced treatment time by 24.5%–25.1% during follow-up and was perceived as more comfortable by patients, supporting the growing shift toward efficient and patient-friendly biofilm management.
• With dental care increasingly shifting toward preventive maintenance, patient comfort, and efficient periodontal treatment, the growing clinical adoption of biofilm-disclosure and air-polishing technologies will continue supporting demand for Guided Biofilm Therapy systems and consumables.

Which Factors are Challenging the Growth of the Guided Biofilm Therapy Market?

• Advanced guided biofilm therapy systems require significant investment in specialized air-polishing equipment, ultrasonic instrumentation, powders, maintenance, and professional training, increasing the overall cost of implementation for dental practices.
• For instance, in September 2024, a study published in BMC Oral Health involving 60 patients with Stage III/IV periodontitis found that GBT and conventional instrumentation produced comparable clinical outcomes, with no significant differences in most periodontal endpoints, potentially limiting the incentive for practices to replace established treatment methods.
• These costs can limit adoption among small dental clinics and price-sensitive practices, particularly where conventional scaling, polishing, and manual instrumentation remain established and less capital-intensive treatment approaches.
• Limited long-term clinical evidence remains a restraint, as current studies have not consistently demonstrated GBT's superiority over conventional periodontal treatment in key outcomes such as probing depth, clinical attachment level, and bleeding on probing.
• For instance, in November 2024, an article published in the Journal of Periodontology evaluated a biofilm-management protocol incorporating air polishing during supportive periodontal care and highlighted the continuing need for further clinical evidence, while noting that the terminology and clinical positioning of GBT remain under discussion.
• Aerosol-generation and infection-control concerns associated with air-polishing procedures can increase operational requirements for dental practices, including high-volume evacuation and additional aerosol-control measures

How is the Guided Biofilm Therapy Market Segmented?

The guided biofilm therapy market is segmented on the basis of product type, technology, technique, indication, and end user.

• By Product Type

On the basis of product type, the guided biofilm therapy market is segmented into guided biofilm therapy kits, air polishing devices, ultrasonic scaling devices, accessories, consumables, and others. The air polishing devices segment dominated the market with a 42.37% share in 2025, owing to their central role in removing dental biofilm, stains, and soft deposits with relatively low patient discomfort. These devices are widely used during periodontal maintenance, prophylaxis, orthodontic treatment, and implant maintenance procedures. Increasing preference for minimally invasive dental procedures is supporting their adoption across dental practices. Technological improvements in powder delivery, nozzle design, and treatment control are further improving clinical efficiency. Their compatibility with modern GBT protocols also strengthens their position within professional dental hygiene workflows.

The ultrasonic scaling devices segment is projected to register the fastest growth at a CAGR of 9.82% from 2026 to 2033, driven by their complementary role in removing residual calculus after biofilm disclosure and air polishing. These devices enable clinicians to target hard deposits while limiting extensive manual instrumentation. Their integration into GBT workflows is strengthening demand for specialized periodontal and implant-compatible tips. Rising periodontal disease prevalence is also increasing the need for professional scaling procedures. Advances in ultrasonic instrumentation are improving precision, ergonomics, and operator control. Increasing adoption of comprehensive periodontal maintenance protocols is further supporting utilization.

• By Technology

On the basis of technology, the guided biofilm therapy market is segmented into air polishing systems, piezoelectric ultrasonic systems, magnetostrictive ultrasonic systems, biofilm disclosure and visualization systems, and others. The air polishing systems segment dominated the market with a 41.59% share in 2025, supported by its fundamental role in the GBT treatment sequence and its ability to efficiently remove biofilm and extrinsic stains. These systems provide controlled powder-and-air delivery for cleaning tooth surfaces and difficult-to-reach areas. Their broad application across periodontal maintenance, prophylaxis, orthodontic care, and implant maintenance contributes to their widespread use. Increasing demand for comfortable alternatives to conventional mechanical plaque removal is further supporting adoption. Improvements in powder formulations and nozzle design are expanding their clinical applications.

The biofilm disclosure and visualization systems segment is projected to register the fastest growth at a CAGR of 11.63% from 2026 to 2033, driven by increasing emphasis on identifying biofilm before mechanical removal. These technologies enable dental professionals to visualize deposits that may otherwise be difficult to detect. Better visualization can help clinicians target treatment more precisely and demonstrate biofilm accumulation to patients. Growing emphasis on patient education and preventive dentistry is supporting adoption of these systems. Digital imaging and visualization technologies are also creating opportunities for more standardized assessment of treatment progress. Increasing integration of visualization into structured GBT workflows can improve treatment consistency.

• By Technique

On the basis of technique, the guided biofilm therapy market is segmented into airflow technology, ultrasonic scaling, rinsing solutions, and others. The airflow technology segment dominated the market with a 48.63% share in 2025, owing to its extensive use for removing biofilm, stains, and soft deposits during professional dental hygiene procedures. Airflow is a core component of the GBT sequence and is generally performed before targeted ultrasonic removal of remaining calculus. The technique supports minimally invasive treatment and can improve patient comfort compared with some conventional mechanical approaches. Increasing utilization in periodontal maintenance, orthodontic care, and implant maintenance is contributing to its broad application. Development of specialized powders is expanding its suitability across different clinical surfaces and indications

The ultrasonic scaling segment is projected to register the fastest growth at a CAGR of 10.79% from 2026 to 2033, driven by its complementary role in removing calculus following biofilm disclosure and airflow treatment. Ultrasonic instruments provide efficient removal of hard deposits while reducing the need for extensive manual scaling. Their targeted application within GBT protocols is increasing demand for specialized tips designed for periodontal and implant procedures. Rising periodontal disease burden is creating additional demand for professional scaling and maintenance. Improvements in ultrasonic technology are also supporting greater precision and operator control. Growing adoption of structured periodontal maintenance workflows is further strengthening this technique.

• By Indication

On the basis of indication, the guided biofilm therapy market is segmented into periodontal disease, dental biofilm management, orthodontic care, peri-implantitis, and others. The periodontal disease segment dominated the market with a 38.56% share in 2025, driven by the widespread requirement for professional biofilm and calculus management among patients with periodontal conditions. GBT combines biofilm disclosure, airflow treatment, and ultrasonic instrumentation within a structured periodontal maintenance workflow. Increasing awareness of periodontal health is encouraging more patients to seek professional preventive and maintenance care. Dental professionals are increasingly emphasizing regular biofilm management to support periodontal health. The broad patient population requiring periodontal maintenance provides a substantial base for GBT procedures.

The peri-implantitis segment is projected to register the fastest growth at a CAGR of 10.17% from 2026 to 2033, driven by the expanding population of patients with dental implants and increasing requirements for long-term implant maintenance. Biofilm accumulation around implants can contribute to peri-implant inflammation, increasing demand for specialized professional care. GBT techniques can provide targeted biofilm removal around implant-supported structures while supporting routine maintenance. Growing adoption of dental implants is expanding the population requiring periodic professional implant care. Increasing awareness of the importance of maintaining peri-implant health is further supporting demand. Development of implant-compatible powders, nozzles, and instrumentation is improving the applicability of GBT in this indication.

• By End User

On the basis of end user, the guided biofilm therapy market is segmented into dental clinics, hospitals, academic institutions, research institutions, and others. The dental clinics segment dominated the market with a 65.13% share in 2025, owing to the high volume of preventive dentistry, periodontal maintenance, professional cleaning, and implant-care procedures performed in these facilities. Dental clinics represent the primary setting for routine GBT procedures because treatment can be incorporated directly into dental hygiene appointments. Increasing patient awareness of professional biofilm management is encouraging clinics to adopt specialized equipment and structured treatment protocols. Private dental practices are also increasingly using advanced preventive technologies to differentiate their services. Availability of dentists and dental hygienists further facilitates routine GBT implementation.

The hospitals segment is projected to register the fastest growth at a CAGR of 12.58% from 2026 to 2033, supported by increasing adoption of standardized oral-care workflows and growing attention to periodontal and peri-implant health. Hospitals can integrate professional biofilm management into broader dental, surgical, and preventive-care pathways. Their institutional structure also supports procurement of standardized equipment and implementation of documented treatment protocols. Growing demand for multidisciplinary patient management is increasing the relevance of oral health within hospital-based care. Advanced GBT equipment can provide hospitals with consistent workflows for biofilm removal and periodontal maintenance. Expansion of hospital dental departments and specialty-care facilities is creating additional opportunities for adoption.

Which Region Holds the Largest Share of the Guided Biofilm Therapy Market?

• North America dominated the guided biofilm therapy market with the largest revenue share of 39.16% in 2025, supported by advanced dental infrastructure, high dental expenditure, and strong adoption of preventive and minimally invasive periodontal care.
• The region also benefits from a mature dental hygiene profession, widespread adoption of advanced air-polishing and ultrasonic technologies, and increasing use of GBT across periodontal maintenance and implant-care procedures. High awareness of preventive oral healthcare and continued adoption of innovative dental technologies are strengthening North America's leadership position in the global market.

U.S. Guided Biofilm Therapy Market Insight

The U.S. guided biofilm therapy market is witnessing strong growth due to rising adoption of advanced preventive dental care, increasing periodontal disease awareness, and growing demand for minimally invasive biofilm-management procedures. The country's mature dental healthcare ecosystem, along with widespread adoption of air-polishing, ultrasonic, and biofilm-disclosure technologies, is driving demand across dental clinics, periodontal practices, and implant-care centers. In addition, growing emphasis on patient comfort, efficient treatment workflows, and professional dental hygiene is accelerating GBT adoption across dental practices.

Asia-Pacific Guided Biofilm Therapy Market Insight

The Asia-Pacific guided biofilm therapy market is expected to witness rapid growth, driven by expanding dental healthcare infrastructure, increasing oral-health awareness, and rising investments in modern dental equipment across countries such as China, India, and Japan. Growing demand for preventive dentistry, increasing adoption of dental implants, and expanding private dental clinic networks are supporting regional market expansion. In addition, rising healthcare expenditure and increasing adoption of minimally invasive dental technologies are accelerating GBT adoption across commercial and specialty dental practices.

Japan Guided Biofilm Therapy Market Insight

The Japan guided biofilm therapy market is witnessing consistent growth due to rising investments in advanced preventive dentistry, periodontal maintenance, and modern dental technologies. Dental clinics and oral-care professionals are increasingly adopting air-polishing and ultrasonic technologies for professional biofilm removal, periodontal maintenance, and implant care. Moreover, increasing integration of patient-centered preventive approaches and the country's aging population are further contributing to demand for efficient and comfortable professional oral-care solutions.

China Guided Biofilm Therapy Market Insight

The China guided biofilm therapy market is growing rapidly, driven by expanding dental infrastructure, increasing awareness of oral health, and rising demand for advanced preventive dental procedures. Growing adoption of air-polishing, ultrasonic scaling, and biofilm-disclosure technologies across private dental clinics is significantly boosting market demand. In addition, rising dental expenditure, increasing dental implant utilization, and rapid modernization of dental practices are positioning China as one of the fastest-growing markets for guided biofilm therapy in the Asia-Pacific region.

U.K. Guided Biofilm Therapy Market Insight

The U.K. guided biofilm therapy market is experiencing steady growth, supported by rising adoption of preventive periodontal care, professional dental hygiene technologies, and minimally invasive biofilm-management procedures. Increasing investments in advanced dental equipment and growing demand for comfortable, efficient treatment solutions are contributing to market growth. Furthermore, integration of air-polishing, ultrasonic scaling, and biofilm-disclosure technologies is improving treatment efficiency and patient experience, positioning the U.K. as an important market for guided biofilm therapy.

Germany Guided Biofilm Therapy Market Insight

The Germany guided biofilm therapy market is expanding steadily due to the country's strong dental healthcare infrastructure, advanced clinical capabilities, and increasing adoption of next-generation oral-care technologies. Dental clinics, periodontal specialists, and implant-care providers are increasingly utilizing GBT protocols for professional biofilm removal, periodontal maintenance, and preventive treatment. Continuous advancements in air-polishing systems, specialized powders, and ultrasonic instrumentation, along with strong emphasis on preventive oral healthcare, are further driving market growth in Germany.

Which are the Top Companies in Guided Biofilm Therapy Market?

The guided biofilm therapy industry is primarily led by well-established companies, including:

• E.M.S. Electro Médical Systems (Switzerland)
• W&H Dentalwerk Bürmoos GmbH (Austria)
• Dentsply Sirona. (U.S.)
• KaVo Dental (Germany)
• NSK / Nakanishi inc. (Japan)
• ACTEON (France)
• COLTENE Group (Switzerland)
• Ultradent Products, Inc. (U.S.)
• Planmeca Oy (Finland)
• Bien-Air Dental SA (Switzerland)
• DÜRR DENTAL SE (Germany)
• HuFriedyGroup (U.S.)
• A-dec, Inc. (U.S.)
• Midmark Corporation (U.S.)
• Young Innovations, Inc. (U.S.)
• Pac-Dent International, Inc. (U.S.)
• Bonart Co., Ltd. (Taiwan)
• Guilin Woodpecker Medical Instrument Co., Ltd. (China)
• MK-dent GmbH (Germany)
• Parkell, Inc. (U.S.)

What are Latest Developments in Guided Biofilm Therapy Market?

• In May 2025, EMS officially presented the new GBT Machine to the U.K. dental market, highlighting its next-generation prophylaxis capabilities and its integration into Guided Biofilm Therapy workflows. The system was positioned as an advanced replacement for the AIRFLOW® Prophylaxis Master, with enhanced workflow efficiency and patient comfort.
• In April 2025, EMS, Electro Medical Systems SA, introduced the new GBT Machine at IDS 2025 in Cologne, Germany, launching the next generation of its Guided Biofilm Therapy equipment. The GBT Machine is the successor to the AIRFLOW® Prophylaxis Master and was designed specifically for GBT treatments, with improvements focused on patient and clinician comfort, treatment efficiency, workflow, and clinical precision. The launch represents a significant product development in professional biofilm-management equipment and strengthens EMS's portfolio of dedicated GBT technologies.
• In March 2025, EMS introduced the new AIRFLOW MAX and PERIOFLOW MAX components as part of its next-generation GBT platform, with AIRFLOW MAX using patented Laminar AIRFLOW Technology for improved visibility, efficiency, and aerosol control, while PERIOFLOW MAX was designed for gentler treatment of periodontal pockets and implant surfaces.
• In May 2024, BDJ Team published a dedicated clinical feature on the use of Guided Biofilm Therapy for preventive dental care, highlighting its combination of erythritol air-polishing and ultrasonic piezo instrumentation. The publication discussed GBT as a structured approach to professional biofilm removal and referenced clinical research supporting its use in periodontal maintenance. This helped strengthen professional awareness of GBT as an emerging approach within preventive dentistry.
• In July 2022, researchers published a randomized controlled trial evaluating Guided Biofilm Therapy using erythritol air-polishing and ultrasonic piezo instrumentation. The study investigated the clinical effectiveness of the combined approach and provided evidence on GBT as a structured method for professional biofilm removal. The publication added clinical validation to the use of air polishing followed by ultrasonic instrumentation within GBT-based periodontal maintenance.

SKU-76713